Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing

Erin M. Scanlon, Rekha Mankad, Cynthia Crowson, Iftikhar Jan Kullo, Sharon L. Mulvagh, Eric Lawrence Matteson, Zoran Kvrgic, John Manley III Davis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study aimed to determine the relationship between noninvasive measures of arterial health and both estimated 10-year cardiovascular risk and measures of disease activity over time in established rheumatoid arthritis. Fifty rheumatoid arthritis patients underwent noninvasive arterial health testing (brachial artery reactivity, aortic augmentation index [AIx], pulse wave velocity, carotid artery intima-media thickness, and carotid artery plaque presence) and assessment of clinical disease activity (tender or swollen joint counts, Clinical Disease Activity Index [CDAI], and Health Assessment Questionnaire II [HAQ-II]). Clinical measures during 3 years before the study visit were averaged. Arterial health testing was compared with the American Heart Association/American College of Cardiology (AHA/ACC) Pooled Cohort Equation. Spearman methods identified correlations between disease activity measures, cardiac biomarkers, and arterial health parameters. Among the patients (mean age, 57.5 years), disease activity was moderate (mean [SD] CDAI, 16.9 [15.3]). At the study visit, corrected aortic augmentation index correlated with CDAI (r = 0.37, P = .009) and HAQ-II (r = 0.33, P = .02). AIx correlated with time-averaged tender joint count (r = 0.37, P = .008), CDAI (r = 0.36, P = .01), HAQ-II (r = 0.36, P = .01), swollen joint count (r = 0.36, P = .10), patient global assessment (r = 0.33, P = .02), physician global assessment (r = 0.35, P = .01), and pain score (r = 0.38, P = .007). The AHA/ACC low-risk group (<5% 10-year risk) had highest prevalence of carotid plaques. Arterial health testing may identify increased risk of cardiovascular disease compared with risk obtained through AHA/ACC Pooled Cohort Equation. Measures of arterial stiffness correlate with the burden of disease activity over time.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalClinical Rheumatology
DOIs
StateAccepted/In press - Dec 17 2016

Fingerprint

Rheumatoid Arthritis
Health
American Heart Association
Joints
Cardiology
Carotid Intima-Media Thickness
Pulse Wave Analysis
Vascular Stiffness
Brachial Artery
Carotid Stenosis
Carotid Arteries
Cardiovascular Diseases
Biomarkers
Physicians
Pain
Surveys and Questionnaires

Keywords

  • Brachial artery reactivity testing
  • Carotid artery intima-media thickness
  • Endothelial dysfunction
  • Flow-mediated dilation
  • Rheumatic disease
  • Swollen joint count
  • Tender joint count

ASJC Scopus subject areas

  • Rheumatology

Cite this

@article{4e3fafeff5db438d84bc434bf3496920,
title = "Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing",
abstract = "This study aimed to determine the relationship between noninvasive measures of arterial health and both estimated 10-year cardiovascular risk and measures of disease activity over time in established rheumatoid arthritis. Fifty rheumatoid arthritis patients underwent noninvasive arterial health testing (brachial artery reactivity, aortic augmentation index [AIx], pulse wave velocity, carotid artery intima-media thickness, and carotid artery plaque presence) and assessment of clinical disease activity (tender or swollen joint counts, Clinical Disease Activity Index [CDAI], and Health Assessment Questionnaire II [HAQ-II]). Clinical measures during 3 years before the study visit were averaged. Arterial health testing was compared with the American Heart Association/American College of Cardiology (AHA/ACC) Pooled Cohort Equation. Spearman methods identified correlations between disease activity measures, cardiac biomarkers, and arterial health parameters. Among the patients (mean age, 57.5 years), disease activity was moderate (mean [SD] CDAI, 16.9 [15.3]). At the study visit, corrected aortic augmentation index correlated with CDAI (r = 0.37, P = .009) and HAQ-II (r = 0.33, P = .02). AIx correlated with time-averaged tender joint count (r = 0.37, P = .008), CDAI (r = 0.36, P = .01), HAQ-II (r = 0.36, P = .01), swollen joint count (r = 0.36, P = .10), patient global assessment (r = 0.33, P = .02), physician global assessment (r = 0.35, P = .01), and pain score (r = 0.38, P = .007). The AHA/ACC low-risk group (<5{\%} 10-year risk) had highest prevalence of carotid plaques. Arterial health testing may identify increased risk of cardiovascular disease compared with risk obtained through AHA/ACC Pooled Cohort Equation. Measures of arterial stiffness correlate with the burden of disease activity over time.",
keywords = "Brachial artery reactivity testing, Carotid artery intima-media thickness, Endothelial dysfunction, Flow-mediated dilation, Rheumatic disease, Swollen joint count, Tender joint count",
author = "Scanlon, {Erin M.} and Rekha Mankad and Cynthia Crowson and Kullo, {Iftikhar Jan} and Mulvagh, {Sharon L.} and Matteson, {Eric Lawrence} and Zoran Kvrgic and Davis, {John Manley III}",
year = "2016",
month = "12",
day = "17",
doi = "10.1007/s10067-016-3515-3",
language = "English (US)",
pages = "1--9",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",

}

TY - JOUR

T1 - Cardiovascular risk assessment in patients with rheumatoid arthritis

T2 - a correlative study of noninvasive arterial health testing

AU - Scanlon, Erin M.

AU - Mankad, Rekha

AU - Crowson, Cynthia

AU - Kullo, Iftikhar Jan

AU - Mulvagh, Sharon L.

AU - Matteson, Eric Lawrence

AU - Kvrgic, Zoran

AU - Davis, John Manley III

PY - 2016/12/17

Y1 - 2016/12/17

N2 - This study aimed to determine the relationship between noninvasive measures of arterial health and both estimated 10-year cardiovascular risk and measures of disease activity over time in established rheumatoid arthritis. Fifty rheumatoid arthritis patients underwent noninvasive arterial health testing (brachial artery reactivity, aortic augmentation index [AIx], pulse wave velocity, carotid artery intima-media thickness, and carotid artery plaque presence) and assessment of clinical disease activity (tender or swollen joint counts, Clinical Disease Activity Index [CDAI], and Health Assessment Questionnaire II [HAQ-II]). Clinical measures during 3 years before the study visit were averaged. Arterial health testing was compared with the American Heart Association/American College of Cardiology (AHA/ACC) Pooled Cohort Equation. Spearman methods identified correlations between disease activity measures, cardiac biomarkers, and arterial health parameters. Among the patients (mean age, 57.5 years), disease activity was moderate (mean [SD] CDAI, 16.9 [15.3]). At the study visit, corrected aortic augmentation index correlated with CDAI (r = 0.37, P = .009) and HAQ-II (r = 0.33, P = .02). AIx correlated with time-averaged tender joint count (r = 0.37, P = .008), CDAI (r = 0.36, P = .01), HAQ-II (r = 0.36, P = .01), swollen joint count (r = 0.36, P = .10), patient global assessment (r = 0.33, P = .02), physician global assessment (r = 0.35, P = .01), and pain score (r = 0.38, P = .007). The AHA/ACC low-risk group (<5% 10-year risk) had highest prevalence of carotid plaques. Arterial health testing may identify increased risk of cardiovascular disease compared with risk obtained through AHA/ACC Pooled Cohort Equation. Measures of arterial stiffness correlate with the burden of disease activity over time.

AB - This study aimed to determine the relationship between noninvasive measures of arterial health and both estimated 10-year cardiovascular risk and measures of disease activity over time in established rheumatoid arthritis. Fifty rheumatoid arthritis patients underwent noninvasive arterial health testing (brachial artery reactivity, aortic augmentation index [AIx], pulse wave velocity, carotid artery intima-media thickness, and carotid artery plaque presence) and assessment of clinical disease activity (tender or swollen joint counts, Clinical Disease Activity Index [CDAI], and Health Assessment Questionnaire II [HAQ-II]). Clinical measures during 3 years before the study visit were averaged. Arterial health testing was compared with the American Heart Association/American College of Cardiology (AHA/ACC) Pooled Cohort Equation. Spearman methods identified correlations between disease activity measures, cardiac biomarkers, and arterial health parameters. Among the patients (mean age, 57.5 years), disease activity was moderate (mean [SD] CDAI, 16.9 [15.3]). At the study visit, corrected aortic augmentation index correlated with CDAI (r = 0.37, P = .009) and HAQ-II (r = 0.33, P = .02). AIx correlated with time-averaged tender joint count (r = 0.37, P = .008), CDAI (r = 0.36, P = .01), HAQ-II (r = 0.36, P = .01), swollen joint count (r = 0.36, P = .10), patient global assessment (r = 0.33, P = .02), physician global assessment (r = 0.35, P = .01), and pain score (r = 0.38, P = .007). The AHA/ACC low-risk group (<5% 10-year risk) had highest prevalence of carotid plaques. Arterial health testing may identify increased risk of cardiovascular disease compared with risk obtained through AHA/ACC Pooled Cohort Equation. Measures of arterial stiffness correlate with the burden of disease activity over time.

KW - Brachial artery reactivity testing

KW - Carotid artery intima-media thickness

KW - Endothelial dysfunction

KW - Flow-mediated dilation

KW - Rheumatic disease

KW - Swollen joint count

KW - Tender joint count

UR - http://www.scopus.com/inward/record.url?scp=85006340367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006340367&partnerID=8YFLogxK

U2 - 10.1007/s10067-016-3515-3

DO - 10.1007/s10067-016-3515-3

M3 - Article

C2 - 27988813

AN - SCOPUS:85006340367

SP - 1

EP - 9

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

ER -